StonvexLoading…
StonvexStonvexStonvexCore line items from RYTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $60.11M | $189.76M | $132.50M | $81.21M |
Operating Income | $-52.36M | $-192.02M | $-144.95M | $-92.30M |
Net Income | $-55.64M | $-196.54M | $-149.03M | $-46.63M |
EPS (Diluted) | $-0.83 | $-3.11 | $-2.38 | $-1.56 |
Total Assets | $442.32M | $480.20M | $506.87M | $372.73M |
Total Liabilities | $204.70M | $210.17M | $211.19M | $239.15M |
Cash & Equivalents | $62.14M | $54.30M | $52.08M | $135.59M |
Free Cash Flow OCF − CapEx | Not available | $-116.63M | Not available | Not available |
Shares Outstanding | 68.45M | 67.21M | 66.68M | 63.91M |